13F HOLDINGS REPORT
BML Capital Management, LLC
Quarter ended Q4 2023 · Filed October 23, 2023 · Accession 0001754960-23-000287
Total Value
$108.9M
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES TR | 46436E718 | 270,000 | $27.2M | 24.96% |
| 2 | SPDR SER TR | 78468R663 | 200,000 | $18.4M | 16.86% |
| 3 | ATEA PHARMACEUTICALS INC | AVIR | 4,800,000 | $14.4M | 13.22% |
| 4 | CYTEIR THERAPEUTICS INC | 23284P103 | 3,250,008 | $9.2M | 8.48% |
| 5 | AVROBIO INC | 05455M100 | 4,001,627 | $6.2M | 5.66% |
| 6 | ADVERUM BIOTECHNOLOGIES INC | 00773U108 | 3,915,000 | $5.9M | 5.39% |
| 7 | TALARIS THERAPEUTICS INC | 87410C104 | 2,000,000 | $5.6M | 5.16% |
| 8 | ELIEM THERAPEUTICS INC | CLYM | 1,938,263 | $5.1M | 4.68% |
| 9 | ATHIRA PHARMA INC | 04746L104 | 1,704,362 | $3.4M | 3.16% |
| 10 | ASTROTECH CORP | ASTC | 220,410 | $2.2M | 2.04% |
| 11 | ORAMED PHARMACEUTICALS INC | ORMP | 781,292 | $2.0M | 1.87% |
| 12 | ARCA BIOPHARMA INC | 00211Y506 | 706,930 | $1.4M | 1.30% |
| 13 | PASSAGE BIO INC | PASG | 2,058,767 | $1.4M | 1.24% |
| 14 | FORTE BIOSCIENCES INC | FBRX | 1,761,702 | $1.2M | 1.07% |
| 15 | MILESTONE PHARMACEUTICALS IN | MIST | 272,500 | $844,750 | 0.78% |
| 16 | ENLIVEN THERAPEUTICS INC | ELVN | 50,000 | $683,000 | 0.63% |
| 17 | RETRACTABLE TECHNOLOGIES INC | RVP | 499,959 | $594,951 | 0.55% |
| 18 | VERRICA PHARMACEUTICALS INC | VRCA | 150,000 | $582,750 | 0.54% |
| 19 | VISTAGEN THERAPEUTICS INC | VTGN | 100,000 | $524,000 | 0.48% |
| 20 | LISATA THERAPEUTICS INC | LSTA | 243,839 | $521,815 | 0.48% |
| 21 | INVESCO QQQ TR | IVZ | 108 | $443,880 | 0.41% |
| 22 | NEXTCURE INC | NXTC | 306,465 | $395,340 | 0.36% |
| 23 | NEOLEUKIN THERAPEUTICS INC | 64049K203 | 98,664 | $389,723 | 0.36% |
| 24 | CALCIMEDICA INC | CALC | 88,781 | $236,113 | 0.22% |
| 25 | RAIN ONCOLOGY INC | 75082Q105 | 72,926 | $62,848 | 0.06% |
| 26 | SURROZEN INC | SRZNW | 89,271 | $43,743 | 0.04% |